cd19 car detection Search Results


96
Miltenyi Biotec cd19 car detection
FIGURE 1 Chimeric antigen receptor <t>(CAR)</t> detection methods. Binding mechanisms of the different CAR detection reagents. (1) The APC- conjugated AffiniPure F(ab')2 fragment goat antihuman IgG, Fcγ fragment specific, also called anti-Fc, binds the human IgG1 derived hinge domain. (2–4) These three methods use a recombinant human <t>CD19</t> protein fragment able to bind the anti-CD19 single-chain fragment variable (scFv). The CD19his (2) is fused to a histidine tag that is recognized by an APC-conjugated antihistidine antibody. The CD19bio (3) is fused to a biotin tag that is recognized by an APC-conjugated antibiotin antibody. The CD19-FITC (4) is directly conjugated to the FITC fluorochrome. [Color figure can be viewed at wileyonlinelibrary.com]
Cd19 Car Detection, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd19+car+detection/CD19+CAR+Detection+Reagent%2C+human/pm37707318-51-51-65
Average 96 stars, based on 1 article reviews
cd19 car detection - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

90
Bristol Myers anti-idiotype antibody detecting anti-cd19-car coupled to af647
FIGURE 1 Chimeric antigen receptor <t>(CAR)</t> detection methods. Binding mechanisms of the different CAR detection reagents. (1) The APC- conjugated AffiniPure F(ab')2 fragment goat antihuman IgG, Fcγ fragment specific, also called anti-Fc, binds the human IgG1 derived hinge domain. (2–4) These three methods use a recombinant human <t>CD19</t> protein fragment able to bind the anti-CD19 single-chain fragment variable (scFv). The CD19his (2) is fused to a histidine tag that is recognized by an APC-conjugated antihistidine antibody. The CD19bio (3) is fused to a biotin tag that is recognized by an APC-conjugated antibiotin antibody. The CD19-FITC (4) is directly conjugated to the FITC fluorochrome. [Color figure can be viewed at wileyonlinelibrary.com]
Anti Idiotype Antibody Detecting Anti Cd19 Car Coupled To Af647, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd19+car+detection/anti+idiotype+antibody+detecting+anti+cd19+car+coupled+to+af647/bio_rxiv__2023__05__30__542829-104-42-43
Average 90 stars, based on 1 article reviews
anti-idiotype antibody detecting anti-cd19-car coupled to af647 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


FIGURE 1 Chimeric antigen receptor (CAR) detection methods. Binding mechanisms of the different CAR detection reagents. (1) The APC- conjugated AffiniPure F(ab')2 fragment goat antihuman IgG, Fcγ fragment specific, also called anti-Fc, binds the human IgG1 derived hinge domain. (2–4) These three methods use a recombinant human CD19 protein fragment able to bind the anti-CD19 single-chain fragment variable (scFv). The CD19his (2) is fused to a histidine tag that is recognized by an APC-conjugated antihistidine antibody. The CD19bio (3) is fused to a biotin tag that is recognized by an APC-conjugated antibiotin antibody. The CD19-FITC (4) is directly conjugated to the FITC fluorochrome. [Color figure can be viewed at wileyonlinelibrary.com]

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology

Article Title: Optimization and validation of in vivo flow cytometry chimeric antigen receptor T cell detection method using CD19his indirect staining.

doi: 10.1002/cyto.a.24796

Figure Lengend Snippet: FIGURE 1 Chimeric antigen receptor (CAR) detection methods. Binding mechanisms of the different CAR detection reagents. (1) The APC- conjugated AffiniPure F(ab')2 fragment goat antihuman IgG, Fcγ fragment specific, also called anti-Fc, binds the human IgG1 derived hinge domain. (2–4) These three methods use a recombinant human CD19 protein fragment able to bind the anti-CD19 single-chain fragment variable (scFv). The CD19his (2) is fused to a histidine tag that is recognized by an APC-conjugated antihistidine antibody. The CD19bio (3) is fused to a biotin tag that is recognized by an APC-conjugated antibiotin antibody. The CD19-FITC (4) is directly conjugated to the FITC fluorochrome. [Color figure can be viewed at wileyonlinelibrary.com]

Article Snippet: See the T erm s and C onditions (https://onlinelibrary.w iley.com /term s-and-conditions) on W iley O nline L ibrary for rules of use; O A articles are governed by the applicable C reative C om m ons L icense together with APC-conjugated antihistidine antibody (Miltenyi Biotec, Bergisch, Gladbach, Germany); (2) the CD19 CAR detection reagent, a biotinylated human CD19 protein, together with APC-conjugated antibiotin antibody (Miltenyi Biotec); (3) the FITC-labeled human CD19 protein (Acro biosystems).

Techniques: Binding Assay, Derivative Assay, Recombinant

FIGURE 2 Comparison between different chimeric antigen receptor (CAR) staining methods. (A) Histograms of CARCIK-CD19 cells staining with the anti-Fc antibody in presence of complete medium (RPMI + 10% fetal bovine serum) or after 1 h incubation in human serum at 100%. Negative controls are shown in the first row and represent the unstained samples. (B) Dot plot of CARCIK-CD19 cells detection on the infusion bag product and in the peripheral blood (PB) patient sample with the three CAR detection methods. Negative controls are shown in the first row and represent the samples stained with only the secondary antibody for the indirect methods (CD19his and CD19bio), while the unstained sample for the direct method (CD19-FITC). (C) Stain index for six independent PB samples stained with the three CAR detection methods. Stain index = ((MFI CAR+ population) – (MFI CAR population))/(2 standard deviation of the CAR population). Bars indicate the mean of each group of samples. (D) Comparison of CD19his, CD19bio, CD19-FITC CAR staining methods in six different PB samples from patients treated with CARCIK-CD19 cells. Statistically significant differences are noted in each figure (*p < 0.05; two-tailed paired t-test). [Color figure can be viewed at wileyonlinelibrary.com]

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology

Article Title: Optimization and validation of in vivo flow cytometry chimeric antigen receptor T cell detection method using CD19his indirect staining.

doi: 10.1002/cyto.a.24796

Figure Lengend Snippet: FIGURE 2 Comparison between different chimeric antigen receptor (CAR) staining methods. (A) Histograms of CARCIK-CD19 cells staining with the anti-Fc antibody in presence of complete medium (RPMI + 10% fetal bovine serum) or after 1 h incubation in human serum at 100%. Negative controls are shown in the first row and represent the unstained samples. (B) Dot plot of CARCIK-CD19 cells detection on the infusion bag product and in the peripheral blood (PB) patient sample with the three CAR detection methods. Negative controls are shown in the first row and represent the samples stained with only the secondary antibody for the indirect methods (CD19his and CD19bio), while the unstained sample for the direct method (CD19-FITC). (C) Stain index for six independent PB samples stained with the three CAR detection methods. Stain index = ((MFI CAR+ population) – (MFI CAR population))/(2 standard deviation of the CAR population). Bars indicate the mean of each group of samples. (D) Comparison of CD19his, CD19bio, CD19-FITC CAR staining methods in six different PB samples from patients treated with CARCIK-CD19 cells. Statistically significant differences are noted in each figure (*p < 0.05; two-tailed paired t-test). [Color figure can be viewed at wileyonlinelibrary.com]

Article Snippet: See the T erm s and C onditions (https://onlinelibrary.w iley.com /term s-and-conditions) on W iley O nline L ibrary for rules of use; O A articles are governed by the applicable C reative C om m ons L icense together with APC-conjugated antihistidine antibody (Miltenyi Biotec, Bergisch, Gladbach, Germany); (2) the CD19 CAR detection reagent, a biotinylated human CD19 protein, together with APC-conjugated antibiotin antibody (Miltenyi Biotec); (3) the FITC-labeled human CD19 protein (Acro biosystems).

Techniques: Comparison, Staining, Incubation, Standard Deviation, Two Tailed Test

FIGURE 3 Specificity and sensitivity of the three chimeric antigen receptor (CAR) staining methods using a recombinant human CD19 protein fragment. (A) The specificity was evaluated by staining healthy donor peripheral blood mononuclear cells with the three CAR detection staining reagents to assess background staining. Data are representative of three different donors acquired in one experiment and bars indicate the mean. (B) The sensitivity was evaluated serially diluting CARCIK-CD19+ cells into untransduced CIK cells at six different dilutions (from 100% to 0%). The graph shows mean values and the standard deviation of three independent experiments for each staining method (CD19his, CD19bio, CD19-FITC). The dotted line represents, in both graphs, the lower limit of quantification (LLOQ) for CD19his, identified at 0.1% CAR+

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology

Article Title: Optimization and validation of in vivo flow cytometry chimeric antigen receptor T cell detection method using CD19his indirect staining.

doi: 10.1002/cyto.a.24796

Figure Lengend Snippet: FIGURE 3 Specificity and sensitivity of the three chimeric antigen receptor (CAR) staining methods using a recombinant human CD19 protein fragment. (A) The specificity was evaluated by staining healthy donor peripheral blood mononuclear cells with the three CAR detection staining reagents to assess background staining. Data are representative of three different donors acquired in one experiment and bars indicate the mean. (B) The sensitivity was evaluated serially diluting CARCIK-CD19+ cells into untransduced CIK cells at six different dilutions (from 100% to 0%). The graph shows mean values and the standard deviation of three independent experiments for each staining method (CD19his, CD19bio, CD19-FITC). The dotted line represents, in both graphs, the lower limit of quantification (LLOQ) for CD19his, identified at 0.1% CAR+

Article Snippet: See the T erm s and C onditions (https://onlinelibrary.w iley.com /term s-and-conditions) on W iley O nline L ibrary for rules of use; O A articles are governed by the applicable C reative C om m ons L icense together with APC-conjugated antihistidine antibody (Miltenyi Biotec, Bergisch, Gladbach, Germany); (2) the CD19 CAR detection reagent, a biotinylated human CD19 protein, together with APC-conjugated antibiotin antibody (Miltenyi Biotec); (3) the FITC-labeled human CD19 protein (Acro biosystems).

Techniques: Staining, Recombinant, Standard Deviation

FIGURE 4 Comparison between chimeric antigen receptor (CAR) expression measured with CD19his flow cytometry and real-time polymerase chain reaction (PCR) data. (A) CAR detection was concurrently assessed in 56 postinfusion peripheral blood samples from 4 patients treated with CARCIK-CD19 cells by flow cytometry using the CD19his method (CD3+CAR+ cell/μL) and qPCR (VCN/μg of DNA). The results show clear inter-method concordance by Pearson correlation test (R = 0.51, p = 0.0008). Data are displayed in a logarithmic scale to better represent values <1 cell/μL. (B,C) Monitoring of CARCIK-CD19 expansion, using CD19his flow cytometry staining and qPCR, in two representative patients. (D–F) CARCIK-CD19 cells were expanded in vitro and purified on a magnetic column for CAR expression. Data are representative of five independent experiments. Untransduced CIK cells, CAR+ and CAR purified cells were then analyzed by qPCR and for their cytotoxic activity. In each histograms columns represent the mean and bars the standard deviation. (D) CAR gene integration measured with quantitative PCR and expressed as vector copy number/μg of DNA. (E) CAR mRNA expression measured with qPCR and expressed as CAR mRNA copies normalized on the reference gene GUS. (F) Cytotoxic activity against a CD19+ REH cell line at a 1:1 effector to target ratio, after 72 h coculture. Statistically significant differences are noted in each figure (*p < 0.05; **p < 0.01; two-tailed paired t-test). [Color figure can be viewed at wileyonlinelibrary.com]

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology

Article Title: Optimization and validation of in vivo flow cytometry chimeric antigen receptor T cell detection method using CD19his indirect staining.

doi: 10.1002/cyto.a.24796

Figure Lengend Snippet: FIGURE 4 Comparison between chimeric antigen receptor (CAR) expression measured with CD19his flow cytometry and real-time polymerase chain reaction (PCR) data. (A) CAR detection was concurrently assessed in 56 postinfusion peripheral blood samples from 4 patients treated with CARCIK-CD19 cells by flow cytometry using the CD19his method (CD3+CAR+ cell/μL) and qPCR (VCN/μg of DNA). The results show clear inter-method concordance by Pearson correlation test (R = 0.51, p = 0.0008). Data are displayed in a logarithmic scale to better represent values <1 cell/μL. (B,C) Monitoring of CARCIK-CD19 expansion, using CD19his flow cytometry staining and qPCR, in two representative patients. (D–F) CARCIK-CD19 cells were expanded in vitro and purified on a magnetic column for CAR expression. Data are representative of five independent experiments. Untransduced CIK cells, CAR+ and CAR purified cells were then analyzed by qPCR and for their cytotoxic activity. In each histograms columns represent the mean and bars the standard deviation. (D) CAR gene integration measured with quantitative PCR and expressed as vector copy number/μg of DNA. (E) CAR mRNA expression measured with qPCR and expressed as CAR mRNA copies normalized on the reference gene GUS. (F) Cytotoxic activity against a CD19+ REH cell line at a 1:1 effector to target ratio, after 72 h coculture. Statistically significant differences are noted in each figure (*p < 0.05; **p < 0.01; two-tailed paired t-test). [Color figure can be viewed at wileyonlinelibrary.com]

Article Snippet: See the T erm s and C onditions (https://onlinelibrary.w iley.com /term s-and-conditions) on W iley O nline L ibrary for rules of use; O A articles are governed by the applicable C reative C om m ons L icense together with APC-conjugated antihistidine antibody (Miltenyi Biotec, Bergisch, Gladbach, Germany); (2) the CD19 CAR detection reagent, a biotinylated human CD19 protein, together with APC-conjugated antibiotin antibody (Miltenyi Biotec); (3) the FITC-labeled human CD19 protein (Acro biosystems).

Techniques: Comparison, Expressing, Flow Cytometry, Real-time Polymerase Chain Reaction, Staining, In Vitro, Purification, Activity Assay, Standard Deviation, Plasmid Preparation, Two Tailed Test

FIGURE 5 Inclusion of CD19his chimeric antigen receptor (CAR) staining method in a 12 colors flow cytometry panel. Representation of CD3 cells staining in a single patient treated with CARCIK-CD19 cells at different time point after infusion, using viSNE map visualization tool. To interpret high-dimensional single-cell data that were produced by multicolor flow cytometry panel, we used a tool based on the viSNE algorithm [32], which allows visualization of high-dimensional cytometry data on a two-dimensional map at single-cell resolution and preserve the nonlinearity [33]. In the viSNE map, cell position reflects their proximity in high-dimensional space based on the similarity of marker expression. The first column shows the distribution of the four major T-cell populations: CD4+ CAR+ cells (blue), CD4+ CAR cells (orange), CD8+ CAR+ cells (green), and CD8+ CAR cells (red). All the other columns show the expression level of each marker included in the panel, excluding CD45 and CD3 used for the identification of the T cells. D, day; M, month after CARCIK infusion. [Color figure can be viewed at wileyonlinelibrary.com]

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology

Article Title: Optimization and validation of in vivo flow cytometry chimeric antigen receptor T cell detection method using CD19his indirect staining.

doi: 10.1002/cyto.a.24796

Figure Lengend Snippet: FIGURE 5 Inclusion of CD19his chimeric antigen receptor (CAR) staining method in a 12 colors flow cytometry panel. Representation of CD3 cells staining in a single patient treated with CARCIK-CD19 cells at different time point after infusion, using viSNE map visualization tool. To interpret high-dimensional single-cell data that were produced by multicolor flow cytometry panel, we used a tool based on the viSNE algorithm [32], which allows visualization of high-dimensional cytometry data on a two-dimensional map at single-cell resolution and preserve the nonlinearity [33]. In the viSNE map, cell position reflects their proximity in high-dimensional space based on the similarity of marker expression. The first column shows the distribution of the four major T-cell populations: CD4+ CAR+ cells (blue), CD4+ CAR cells (orange), CD8+ CAR+ cells (green), and CD8+ CAR cells (red). All the other columns show the expression level of each marker included in the panel, excluding CD45 and CD3 used for the identification of the T cells. D, day; M, month after CARCIK infusion. [Color figure can be viewed at wileyonlinelibrary.com]

Article Snippet: See the T erm s and C onditions (https://onlinelibrary.w iley.com /term s-and-conditions) on W iley O nline L ibrary for rules of use; O A articles are governed by the applicable C reative C om m ons L icense together with APC-conjugated antihistidine antibody (Miltenyi Biotec, Bergisch, Gladbach, Germany); (2) the CD19 CAR detection reagent, a biotinylated human CD19 protein, together with APC-conjugated antibiotin antibody (Miltenyi Biotec); (3) the FITC-labeled human CD19 protein (Acro biosystems).

Techniques: Staining, Flow Cytometry, Produced, Cytometry, Marker, Expressing

FIGURE 6 Application of the CD19his staining method on different commercial chimeric antigen receptor (CAR)-T products and within different sample sources. (A) Representative dot plots of three peripheral blood (PB) samples from patients previously infused with tisagenlecleucel (Kymriah®), axicabtagene ciloleucel (Yescarta®),brexucabtagene autoleucel (Tecartus®) and lisocabtagene maraleucel (Breyanzi®). (B) Representative dot plots of CAR detection on different sample sources: bone marrow (BM), pleural effusion and cerebrospinal fluid (CSF) in patients infused with CARCIK-CD19 cells. [Color figure can be viewed at wileyonlinelibrary.com]

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology

Article Title: Optimization and validation of in vivo flow cytometry chimeric antigen receptor T cell detection method using CD19his indirect staining.

doi: 10.1002/cyto.a.24796

Figure Lengend Snippet: FIGURE 6 Application of the CD19his staining method on different commercial chimeric antigen receptor (CAR)-T products and within different sample sources. (A) Representative dot plots of three peripheral blood (PB) samples from patients previously infused with tisagenlecleucel (Kymriah®), axicabtagene ciloleucel (Yescarta®),brexucabtagene autoleucel (Tecartus®) and lisocabtagene maraleucel (Breyanzi®). (B) Representative dot plots of CAR detection on different sample sources: bone marrow (BM), pleural effusion and cerebrospinal fluid (CSF) in patients infused with CARCIK-CD19 cells. [Color figure can be viewed at wileyonlinelibrary.com]

Article Snippet: See the T erm s and C onditions (https://onlinelibrary.w iley.com /term s-and-conditions) on W iley O nline L ibrary for rules of use; O A articles are governed by the applicable C reative C om m ons L icense together with APC-conjugated antihistidine antibody (Miltenyi Biotec, Bergisch, Gladbach, Germany); (2) the CD19 CAR detection reagent, a biotinylated human CD19 protein, together with APC-conjugated antibiotin antibody (Miltenyi Biotec); (3) the FITC-labeled human CD19 protein (Acro biosystems).

Techniques: Staining